RUNX1突变型急性髓系白血病患者中胚系RUNX1突变的高频率
该研究基于Leucegene RUNX1急性髓系白血病(AML)患者队列,分析胚系与获得性RUNX1突变的比例。结果显示该队列中30%的RUNX1突变为胚系;胚系RUNX1突变AML中NRAS突变及信号通路激活相关突变频率更高;2例(母子)同时携带胚系RUNX1与CEBPA突变,AML发病年龄分别为59岁和27岁。作者认为该队列胚系RUNX1突变频率高于预期,并强调在考虑亲属供者异基因干细胞移植时检测RUNX1突变的重要性。
要点
- Leucegene RUNX1突变AML队列中30%的RUNX1突变为胚系。
- 胚系RUNX1突变AML中NRAS突变及信号通路激活相关突变频率更高。
- 母子2例同时携带胚系RUNX1与CEBPA突变,AML发病年龄分别为59岁和27岁。
核心结论
- Leucegene队列中胚系RUNX1突变频率高于预期。
- 在考虑使用亲属供者进行异基因干细胞移植时,检测RUNX1突变具有重要性。
研究设计与样本
- 利用Leucegene RUNX1 AML患者队列,分析胚系与获得性RUNX1突变的比例。
主要发现
- 该AML队列中30%的RUNX1突变为胚系。
- 胚系RUNX1突变AML中NRAS突变及已知激活多种信号通路的其他突变频率更高。
- 2例患者(母子)同时携带胚系RUNX1与CEBPA突变,AML发病年龄分别为59岁和27岁。
临床怎么用
- 作者认为,在考虑使用亲属供者进行异基因干细胞移植时,检测RUNX1突变具有重要性。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RUNX1 is mutated in ∼10% of adult acute myeloid leukemia (AML). Although most RUNX1 mutations in this disease are believed to be acquired, they can also be germline. Indeed, germline RUNX1 mutations result in the well-described autosomal-dominant familial platelet disorder with predisposition to hematologic malignancies (RUNX1-FPD, FPD/AML, FPDMM); ∼44% of affected individuals progress to AML or myelodysplastic syndromes. Using the Leucegene RUNX1 AML patient group, we sought to investigate the proportion of germline vs acquired RUNX1 mutations in this cohort. Our results showed that 30% of RUNX1 mutations in our AML cohort are germline. Molecular profiling revealed higher frequencies of NRAS mutations and other mutations known to activate various signaling pathways in these patients with RUNX1 germline-mutated AML. Moreover, 2 patients (mother and son) had co-occurrence of RUNX1 and CEBPA germline mutations, with variable AML disease onset at 59 and 27 years, respectively. Together, these data suggest a higher than anticipated frequency of germline RUNX1 mutations in the Leucegene cohort and further highlight the importance of testing for RUNX1 mutations in instances in which allogeneic stem cell transplantation using a related donor is envisioned.
引用
- Simon L, Spinella JF, Yao CY, et al. High frequency of germline RUNX1 mutations in patients with RUNX1-mutated AML. Blood. 2020. PMID: 32315381. doi:10.1182/blood.2019003357
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。